Equity - Narrative (Details)				11 Months Ended	12 Months Ended
	Nov. 06, 2020 USD ($) $ / shares shares	Sep. 18, 2020 shares	Dec. 24, 2019 USD ($) $ / shares shares	Dec. 31, 2019 USD ($) shares	Dec. 31, 2020 USD ($) shares	Jan. 31, 2019 USD ($)	Sep. 17, 2020 shares
Subsidiary, Sale of Stock [Line Items]
Reverse stock split ratio		0.2
Common stock, shares outstanding (in shares) | shares		67,200,000		67,178,054	82,575,064		335,900,000
Proceeds from the issuance of common stock				$ 50,415,000	$ 50,000,000	$ 46,084,000
Transaction costs				$ 912,000	$ 48,000	1,707,000
Number of common stock shares into which warrants may be converted (in shares) | shares			3,358,732
Exercise price of warrants (in dollars per share) | $ / shares			$ 1.44
Warrants outstanding (in shares) | shares				8,620,082	5,821,137
Dividends paid				$ 0	$ 0	$ 0
Private placement
Subsidiary, Sale of Stock [Line Items]
Consideration received on sale of stock	$ 50,000,000.0
Shares issued (in shares) | shares	14,970,060		35,075,690
Share price (in dollars per share) | $ / shares	$ 3.34		$ 1.43
Proceeds from the issuance of common stock	$ 50,000,000.0		$ 50,000,000.0
Transaction costs			$ 900,000
Number of common stock shares into which warrants may be converted (in shares) | shares			5,261,350
Exercise price of warrants (in dollars per share) | $ / shares			$ 1.58
Minimum volume weighted average common stock price to warrant exercise price, premium, percentage			50.00%